BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 34448555)

  • 1. Treatment patterns and a prognostic scoring system for elderly acute myeloid leukemia patients: a retrospective multicenter cohort study in China.
    Zhang C; Wan W; Zhang S; Wang J; Feng R; Li J; Chai J; Zhou H; Wang L; Zhong Y; Mo X; Shen M; Jing H; Liu H
    Cancer Biol Med; 2021 Aug; 19(6):871-83. PubMed ID: 34448555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Evaluation of Treatment Patterns and Outcomes in Elderly Patients Newly Diagnosed With Acute Myeloid Leukemia: A Retrospective Analysis of Electronic Medical Records From US Community Oncology Practices.
    Ma E; Bonthapally V; Chawla A; Lefebvre P; Swords R; Lafeuille MH; Fortier J; Emond B; Duh MS; Dezube BJ
    Clin Lymphoma Myeloma Leuk; 2016 Nov; 16(11):625-636.e3. PubMed ID: 27686689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Standard-Intensity Induction and Intermediate/High-Dose Cytarabine Consolidation Can Improve Survival for Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia: A Retrospective Cohort Study.
    Wang L; Zhao N; Zhou L; Tong J; Xue L; Zhang L; Han Y; Wang X; Geng L; Tang B; Liu H; Zhu W; Cai X; Liu X; Zhu X; Sun Z; Zheng C
    Clin Interv Aging; 2022; 17():55-64. PubMed ID: 35082491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The outcome and prognostic factors of 248 elderly patients with acute myeloid leukemia treated with standard-dose or low-intensity induction therapy.
    Chen Y; Yang T; Zheng X; Yang X; Zheng Z; Zheng J; Liu T; Hu J
    Medicine (Baltimore); 2016 Jul; 95(30):e4182. PubMed ID: 27472687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Results of intensive chemotherapy in 998 patients age 65 years or older with acute myeloid leukemia or high-risk myelodysplastic syndrome: predictive prognostic models for outcome.
    Kantarjian H; O'brien S; Cortes J; Giles F; Faderl S; Jabbour E; Garcia-Manero G; Wierda W; Pierce S; Shan J; Estey E
    Cancer; 2006 Mar; 106(5):1090-8. PubMed ID: 16435386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment Pattern, Financial Burden, and Outcomes in Elderly Patients with Acute Myeloid Leukemia in Korea: A Nationwide Cohort Study.
    Ha H; Jeong Y; Lim JH; Suh YJ
    Int J Environ Res Public Health; 2022 Feb; 19(4):. PubMed ID: 35206499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-World Treatment Patterns and Clinical Outcomes in Korean Patients With AML Ineligible for First-Line Intensive Chemotherapy: A Subanalysis of the CURRENT Study, a Non-Interventional, Retrospective Chart Review.
    Bang SM; Kang KW; Song IC; Llamas C; Duan Y; Jeong JY; Lee JH
    J Korean Med Sci; 2023 Nov; 38(44):e345. PubMed ID: 37967874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient characteristics, treatment patterns, and mortality in elderly patients newly diagnosed with acute myeloid leukemia meeting ineligibility criteria for high intensity chemotherapy.
    Li S; Ji Y; Peng Y; Kota V; Kim C
    Leuk Lymphoma; 2022 Jan; 63(1):131-141. PubMed ID: 34643153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Reduced-Intensity Idarubicin and Daunorubicin Plus Cytarabine as Induction Chemotherapy for Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia.
    Liu H; Fu R; Li L; Wang G; Song J; Ruan E; Wang H; Wu Y; Wang X; Ding K; Shao Z
    Clin Drug Investig; 2017 Feb; 37(2):167-174. PubMed ID: 27722823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Addition of Hypomethylating Agents to Low-Intensity Induction Chemotherapy Does Not Improve Outcomes in Elderly Acute Myeloid Leukemia Patients: A Single-Center Retrospective Study.
    Liu D; Wang X; Tong J; Zhou L; Chen E; Zhou Z; Xue L; Zhang X; Sun G; Zheng C
    Medicina (Kaunas); 2023 Jan; 59(1):. PubMed ID: 36676738
    [No Abstract]   [Full Text] [Related]  

  • 11. Prediction of survival with lower intensity therapy among older patients with acute myeloid leukemia.
    Sasaki K; Ravandi F; Kadia TM; Borthakur G; Short NJ; Jain N; Daver NG; Jabbour EJ; Garcia-Manero G; Loghavi S; Patel KP; Montalban-Bravo G; Masarova L; DiNardo CD; Kantarjian HM
    Cancer; 2023 Apr; 129(7):1017-1029. PubMed ID: 36715486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Real-world treatment patterns and clinical outcomes in patients with AML unfit for first-line intensive chemotherapy
    Miyamoto T; Sanford D; Tomuleasa C; Hsiao HH; Olivera LJE; Enjeti AK; Gimenez Conca A; Castillo TBD; Girshova L; Martelli MP; Guvenc B; Delgado A; Duan Y; Garbayo Guijarro B; Llamas C; Lee JH
    Leuk Lymphoma; 2022 Apr; 63(4):928-938. PubMed ID: 35147482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Comparison of Inpatient and Outpatient-Based Chemotherapy Regimens for the Treatment of Acute Myeloid Leukaemia In The Elderly.
    Daly AB; Cuthbert R; Finnegan D; Arnold C; Craddock C; McMullin MF
    Ulster Med J; 2019 Jan; 88(1):25-29. PubMed ID: 30675075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High response rate for treatment with gemtuzumab ozogamicin and cytarabine in elderly patients with acute myeloid leukemia and favorable and intermediate-I cytogenetic risk.
    Tavor S; Rahamim E; Sarid N; Rozovski U; Gibstein L; Aviv F; Kirsner I; Naparstek E
    Clin Lymphoma Myeloma Leuk; 2012 Dec; 12(6):438-43. PubMed ID: 23017331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of induction chemotherapy with intermediate-dosed cytarabine and subsequent allogeneic stem cell transplantation on the outcome of high-risk acute myeloid leukemia.
    Fleischmann M; Schnetzke U; Frietsch JJ; Sayer HG; Schrenk K; Hammersen J; Glaser A; Hilgendorf I; Hochhaus A; Scholl S
    J Cancer Res Clin Oncol; 2022 Jun; 148(6):1481-1492. PubMed ID: 34297206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Curative Efficacy and Survival Analysis of Low-Intensity Traditional Chemotherapy Regimen in the Elderly Patients with Acute Myeloid Leukemia (non-M
    Wang ZQ; Dai XB; Hua HY; Gao HQ; Zhu WY; Zhou Y; Zhang Y; Wu S; Li J; Zhao Y; Xu ZQ; Zhu XJ; Sun XM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Oct; 28(5):1516-1522. PubMed ID: 33067947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment patterns and comparative effectiveness in elderly acute myeloid leukemia patients (age 70 years or older): the Lyon-university hospital experience.
    Heiblig M; Le Jeune C; Elhamri M; Balsat M; Tigaud I; Plesa A; Barraco F; Labussière H; Ducastelle S; Nicolini F; Wattel E; Salles G; Thomas X
    Leuk Lymphoma; 2017 Jan; 58(1):110-117. PubMed ID: 27184036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of early (4-week) mortality in acute myeloid leukemia with intensive chemotherapy.
    Sasaki K; Kadia T; Begna K; DiNardo CD; Borthakur G; Short NJ; Jain N; Daver N; Jabbour E; Garcia-Manero G; Bravo GM; Masarova L; Pierce S; Konopleva M; Ravandi F; Tefferi A; Kantarjian H
    Am J Hematol; 2022 Jan; 97(1):68-78. PubMed ID: 34716921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The response to induction therapy is crucial for the treatment outcomes of elderly patients with acute myeloid leukemia: single-institution experience.
    Tasaki T; Yamauchi T; Matsuda Y; Takai M; Ookura M; Lee S; Tai K; Ikegaya S; Kishi S; Yoshida A; Urasaki Y; Iwasaki H; Ueda T
    Anticancer Res; 2014 Oct; 34(10):5631-6. PubMed ID: 25275066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive factors for latency period and a prognostic model for survival in patients with therapy-related acute myeloid leukemia.
    Ornstein MC; Mukherjee S; Mohan S; Elson P; Tiu RV; Saunthararajah Y; Kendeigh C; Advani A; Kalaycio M; Maciejewski JP; Sekeres MA
    Am J Hematol; 2014 Feb; 89(2):168-73. PubMed ID: 24123154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.